News
20 February 2026
From Quality to Public Trust
In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and…
3 February 2026
Dexa Medica Receives the 2026 BPOM Achievement Award as Indonesia’s Leading Phytopharmaceutical Company
Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical…
30 January 2026
Dexa Group’s Consistent Reputation Management Wins the 8th Indonesia Public Relations Awards
Winning the award for eight consecutive times, Dexa Group demonstrates long-term consistency in building public trust. This commitment has once again led Dexa Group to receive the Indonesia Public Relations Awards (IPRA) 2026 with the title of Best Public Relations 2026 in Public Trust Building through Ethical Pharmaceutical Practices. This…
1 August 2022
Dexa Award Science Scholarship 2022 Stimulates Innovation to Build Health Independence
The Indonesian government continues to encourage the resilience and independence of the healthcare industry, as imports dominate 90% of its domestic pharmaceutical raw materials and health spending. In addition, 88% of medical device transactions through electronic catalogs (e-catalogs) are imported products. Meanwhile, research and development funds are only about 0.2%…
8 July 2022
Prevent Stunting, Dexa Group’s Green Pharmacy Becomes The Partner of BKKBN
Indonesia's 29th National Family Day (Harganas) was celebrated with the theme "Let's Prevent Stunting for Stunting-Free Family". President Joko Widodo (Jokowi) said that the government had appointed the National Population and Family Planning Agency (BKKBN) to reduce the prevalence of stunting to 14% in 2024. Therefore, BKKBN collaborates with several…
6 July 2022
Mr. Ferry A. Soetikno as a Speaker at the Advisory Board Sharing Session #7: Drug Raw Material Independence as a Part of the Dynamics of the Indonesian Pharmaceutical Industry
The Covid-19 epidemic has given Indonesia's pharmaceutical sector a fresh start. In stark contrast to the average 5–10% growth rate, the pharmaceutical sector shrank by -1.6 percent. Meanwhile, a supply shock made it challenging for the nation to get medical raw materials (BBO) since imports met 90% of BBO requirements.…
1 July 2022
Actively Contributing to Overcoming Health Problems, Dexa Group Wins Indonesia Best CSR Award 2022
Dexa Group received the Outstanding Program in Prioritizing Public Health Needs award from Warta Ekonomi's Indonesia Best CSR Award 2022 for its contribution to the healthcare industry. This honor is granted in recognition of Dexa Group's significant work putting social responsibility and environmental responsibility initiatives into action. On Thursday, June…
25 June 2022
The ‘Bangga Buatan Indonesia’ Movement Promotes Pharmacy Product Independence
Dexa Group participated in the Proudly Made in Indonesia 2022 event once more to accelerate the independence of domestic local products. On Thursday, June 23, 2022, the Bangga Buatan Indonesia (BBI) event with the title Lagawi Fest (Lampung Bangga Wirausaha Industri Festival) Satu Bumi Juta Karya was held on Tegal…
14 June 2022
STIMUNO Wins Top Brand For Kids for the 12th Time
STIMUNO has served as Indonesia's first phytopharmaceutical immunomodulator for over two decades. It also has won several honors since its initial release in 1999. For the 12th year in a row, STIMUNO syrup won the Top Brand For Kids Awards in the Children's Immune System Vitamins category. Marketing Magazine and…
9 June 2022
35 Health Offices in Central Java Support the Use of Indonesian Indigenous Modern Medicines
The ‘Bangga Buatan Indonesia’ Movement (BBI) is supported by 35 District/City Health Offices in Central Java Province, which provide the Special Allocation Fund (DAK) and the APBD for health expenditure on Indonesian Indigenous Modern Medicines (OMAI). Thie program is not just to comply with Presidential Instruction (Inpres) No. 2 of…